Dabigatran Etexilate Compared With Enoxaparin in Prevention of Venous Thromboembolism (VTE) Following Total Hip Arthroplasty

PHASE3CompletedINTERVENTIONAL
Enrollment

2,055

Participants

Timeline

Start Date

March 31, 2008

Primary Completion Date

September 30, 2009

Conditions
Venous Thromboembolism
Interventions
DRUG

Enoxaparin

40 mg once daily

DRUG

Dabigatran etexilate

220 mg once daily

Trial Locations (108)

Unknown

1160.64.01005 Boehringer Ingelheim Investigational Site, La Jolla

1160.64.01010 Boehringer Ingelheim Investigational Site, Aurora

1160.64.01009 Boehringer Ingelheim Investigational Site, Englewood

1160.64.01012 Boehringer Ingelheim Investigational Site, Clearwater

1160.64.01006 Boehringer Ingelheim Investigational Site, Lexington

1160.64.01003 Boehringer Ingelheim Investigational Site, Missoula

1160.64.01007 Boehringer Ingelheim Investigational Site, Charleston

1160.64.01013 Boehringer Ingelheim Investigational Site, Conway

1160.64.01002 Boehringer Ingelheim Investigational Site, Houston

1160.64.01011 Boehringer Ingelheim Investigational Site, Spokane

1160.64.2003 Boehringer Ingelheim Investigational Site, Daws Park

1160.64.2002 Boehringer Ingelheim Investigational Site, Box Hill

1160.64.2001 Boehringer Ingelheim Investigational Site, Windsor

1160.64.2004 Boehringer Ingelheim Investigational Site, Nedlands

1160.64.4004 Boehringer Ingelheim Investigational Site, Graz

1160.64.4002 Boehringer Ingelheim Investigational Site, Linz

1160.64.4001 Boehringer Ingelheim Investigational Site, Vienna

1160.64.4003 Boehringer Ingelheim Investigational Site, Wels

1160.64.5004 Boehringer Ingelheim Investigational Site, Brussels

1160.64.5002 Boehringer Ingelheim Investigational Site, Deurne

1160.64.5005 Boehringer Ingelheim Investigational Site, Lanaken

1160.64.5001 Boehringer Ingelheim Investigational Site, Leuven

1160.64.6009 Boehringer Ingelheim Investigational Site, Edmonton

1160.64.6002 Boehringer Ingelheim Investigational Site, Red Deer

1160.64.6012 Boehringer Ingelheim Investigational Site, Ajax

1160.64.6003 Boehringer Ingelheim Investigational Site, Belleville

1160.64.6004 Boehringer Ingelheim Investigational Site, Cambridge

1160.64.6008 Boehringer Ingelheim Investigational Site, Kitchener

1160.64.6011 Boehringer Ingelheim Investigational Site, Oshawa

1160.64.6005 Boehringer Ingelheim Investigational Site, Sarnia

1160.64.6007 Boehringer Ingelheim Investigational Site, Stratford

1160.64.6013 Boehringer Ingelheim Investigational Site, Windsor

1160.64.7004 Boehringer Ingelheim Investigational Site, Chomutov

1160.64.7005 Boehringer Ingelheim Investigational Site, Jihlava

1160.64.7003 Boehringer Ingelheim Investigational Site, Kolín

1160.64.7001 Boehringer Ingelheim Investigational Site, Pilsen

1160.64.7002 Boehringer Ingelheim Investigational Site, Prague

1160.64.8004 Boehringer Ingelheim Investigational Site, Frederiksberg

1160.64.8003 Boehringer Ingelheim Investigational Site, Herlev

1160.64.8001 Boehringer Ingelheim Investigational Site, Hørsholm

1160.64.8002 Boehringer Ingelheim Investigational Site, Silkeborg

1160.64.9002 Boehringer Ingelheim Investigational Site, Jyväskylä

1160.64.9001 Boehringer Ingelheim Investigational Site, Oulu

1160.64.9003 Boehringer Ingelheim Investigational Site, Tampere

1160.64.1104 Boehringer Ingelheim Investigational Site, Garmisch-Partenkirchen

1160.64.1101 Boehringer Ingelheim Investigational Site, Mainz

1160.64.1103 Boehringer Ingelheim Investigational Site, Markgröningen

1160.64.1102 Boehringer Ingelheim Investigational Site, Rheinfelden

1160.64.1201 Boehringer Ingelheim Investigational Site, Gyula

1160.64.1203 Boehringer Ingelheim Investigational Site, Kecskemét

1160.64.1202 Boehringer Ingelheim Investigational Site, Szeged

1160.64.1204 Boehringer Ingelheim Investigational Site, Székesfehérvár

1160.64.9105 Boehringer Ingelheim Investigational Site, Ahmedabad

1160.64.9112 Boehringer Ingelheim Investigational Site, Andhra Pradesh

1160.64.9109 Boehringer Ingelheim Investigational Site, Andhra Predesh

1160.64.9103 Boehringer Ingelheim Investigational Site, Bangalore

1160.64.9108 Boehringer Ingelheim Investigational Site, Bangalore

1160.64.9107 Boehringer Ingelheim Investigational Site, Baroda

1160.64.9110 Boehringer Ingelheim Investigational Site, Mangalore

1160.64.9104 Boehringer Ingelheim Investigational Site, Mohali

1160.64.9111 Boehringer Ingelheim Investigational Site, New Delhi

1160.64.9106 Boehringer Ingelheim Investigational Site, Pune

1160.64.9101 Boehringer Ingelheim Investigational Site, Ramdaspeth Nagpur

1160.64.9102 Boehringer Ingelheim Investigational Site, Secunderabad

1160.64.9113 Boehringer Ingelheim Investigational Site, Vadodara

1160.64.1401 Boehringer Ingelheim Investigational Site, Bologna

1160.64.1405 Boehringer Ingelheim Investigational Site, Parma

1160.64.1402 Boehringer Ingelheim Investigational Site, Pavia

1160.64.1407 Boehringer Ingelheim Investigational Site, Reggio Emilia

1160.64.1403 Boehringer Ingelheim Investigational Site, Roma

1160.64.1404 Boehringer Ingelheim Investigational Site, Torino

1160.64.1503 Boehringer Ingelheim Investigational Site, Amsterdam

1160.64.1507 Boehringer Ingelheim Investigational Site, Amsterdam

1160.64.1501 Boehringer Ingelheim Investigational Site, Hilversum

1160.64.1506 Boehringer Ingelheim Investigational Site, Hoofddorp

1160.64.1510 Boehringer Ingelheim Investigational Site, Leiden

1160.64.1505 Boehringer Ingelheim Investigational Site, Sittard

1160.64.1508 Boehringer Ingelheim Investigational Site, Zwolle

1160.64.3001 Boehringer Ingelheim Investigational Site, Takapuna Auckland

1160.64.1603 Boehringer Ingelheim Investigational Site, Ålesund

1160.64.1601 Boehringer Ingelheim Investigational Site, Bodø

1160.64.1606 Boehringer Ingelheim Investigational Site, Elverum

1160.64.1604 Boehringer Ingelheim Investigational Site, Lillehammer

1160.64.1605 Boehringer Ingelheim Investigational Site, Tynset

1160.64.1702 Boehringer Ingelheim Investigational Site, Krakow

1160.64.1704 Boehringer Ingelheim Investigational Site, Krakow

1160.64.1705 Boehringer Ingelheim Investigational Site, Lodz

1160.64.1703 Boehringer Ingelheim Investigational Site, Piekary Śląskie

1160.64.1701 Boehringer Ingelheim Investigational Site, Warsaw

1160.64.1801 Boehringer Ingelheim Investigational Site, Bryanston

1160.64.1804 Boehringer Ingelheim Investigational Site, Cape Western Province

1160.64.1802 Boehringer Ingelheim Investigational Site, Plumstead

1160.64.1904 Boehringer Ingelheim Investigational Site, Alcorcón (Madrid)

1160.64.1906 Boehringer Ingelheim Investigational Site, Barcelona

1160.64.1908 Boehringer Ingelheim Investigational Site, Fuenlabrada

1160.64.1901 Boehringer Ingelheim Investigational Site, Madrid

1160.64.1907 Boehringer Ingelheim Investigational Site, Madrid

1160.64.1905 Boehringer Ingelheim Investigational Site, Valencia

1160.64.2101 Boehringer Ingelheim Investigational Site, Gothenburg

1160.64.2112 Boehringer Ingelheim Investigational Site, Halmstad

1160.64.2105 Boehringer Ingelheim Investigational Site, Hässleholm

1160.64.2109 Boehringer Ingelheim Investigational Site, Kalmar

1160.64.2103 Boehringer Ingelheim Investigational Site, Kungälv

1160.64.2106 Boehringer Ingelheim Investigational Site, Lidköping

1160.64.2102 Boehringer Ingelheim Investigational Site, Motala

1160.64.2108 Boehringer Ingelheim Investigational Site, Stockholm

1160.64.2111 Boehringer Ingelheim Investigational Site, Uppsala

1160.64.2107 Boehringer Ingelheim Investigational Site, Varberg

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY